Cargando…
The production of UL16-binding protein 1 targeted pigs using CRISPR technology
Two sgRNAs were designed to target the region of exon 2 of the pULBP1 gene by microinjection. The co-injection of modified Cas9-D10A nickase with a pair of sgRNAs into the zygote’s cytoplasm easily and efficiently generated biallelic modification of the pULBP1 gene in one step. Five out of nine F0 g...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766454/ https://www.ncbi.nlm.nih.gov/pubmed/29354381 http://dx.doi.org/10.1007/s13205-018-1107-4 |
_version_ | 1783292356013850624 |
---|---|
author | Joanna, Zeyland Magdalena, Hryhorowicz Agnieszka, Nowak-Terpiłowska Jacek, Jura Ryszard, Słomski Zdzisław, Smorąg Barbara, Gajda Daniel, Lipiński |
author_facet | Joanna, Zeyland Magdalena, Hryhorowicz Agnieszka, Nowak-Terpiłowska Jacek, Jura Ryszard, Słomski Zdzisław, Smorąg Barbara, Gajda Daniel, Lipiński |
author_sort | Joanna, Zeyland |
collection | PubMed |
description | Two sgRNAs were designed to target the region of exon 2 of the pULBP1 gene by microinjection. The co-injection of modified Cas9-D10A nickase with a pair of sgRNAs into the zygote’s cytoplasm easily and efficiently generated biallelic modification of the pULBP1 gene in one step. Five out of nine F0 generation piglets showed insertions or deletions in the targeting site of the pULBP1 gene, indicating that pULBP1 mutation efficiency reached about 56% (5/9). Quantitative determination of pULBP1 showed approximately a 1.53-fold reduction in the amount of protein ULBP1 on the cell surface (ELISA). A human NK-cell cytotoxicity test leads to the conclusion that higher cell viability is observed for −/− ULBP1 (survival rate 85.36%) compared to +/+ ULBP1 (69.58%). ULBP1-KO pigs will provide a more progressive xenograft source for further research studies, especially those measuring the effects of abolishing the gene function in terms of the complexity of the immunological interactions. |
format | Online Article Text |
id | pubmed-5766454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-57664542018-01-19 The production of UL16-binding protein 1 targeted pigs using CRISPR technology Joanna, Zeyland Magdalena, Hryhorowicz Agnieszka, Nowak-Terpiłowska Jacek, Jura Ryszard, Słomski Zdzisław, Smorąg Barbara, Gajda Daniel, Lipiński 3 Biotech Original Article Two sgRNAs were designed to target the region of exon 2 of the pULBP1 gene by microinjection. The co-injection of modified Cas9-D10A nickase with a pair of sgRNAs into the zygote’s cytoplasm easily and efficiently generated biallelic modification of the pULBP1 gene in one step. Five out of nine F0 generation piglets showed insertions or deletions in the targeting site of the pULBP1 gene, indicating that pULBP1 mutation efficiency reached about 56% (5/9). Quantitative determination of pULBP1 showed approximately a 1.53-fold reduction in the amount of protein ULBP1 on the cell surface (ELISA). A human NK-cell cytotoxicity test leads to the conclusion that higher cell viability is observed for −/− ULBP1 (survival rate 85.36%) compared to +/+ ULBP1 (69.58%). ULBP1-KO pigs will provide a more progressive xenograft source for further research studies, especially those measuring the effects of abolishing the gene function in terms of the complexity of the immunological interactions. Springer Berlin Heidelberg 2018-01-13 2018-01 /pmc/articles/PMC5766454/ /pubmed/29354381 http://dx.doi.org/10.1007/s13205-018-1107-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Joanna, Zeyland Magdalena, Hryhorowicz Agnieszka, Nowak-Terpiłowska Jacek, Jura Ryszard, Słomski Zdzisław, Smorąg Barbara, Gajda Daniel, Lipiński The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title | The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title_full | The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title_fullStr | The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title_full_unstemmed | The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title_short | The production of UL16-binding protein 1 targeted pigs using CRISPR technology |
title_sort | production of ul16-binding protein 1 targeted pigs using crispr technology |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766454/ https://www.ncbi.nlm.nih.gov/pubmed/29354381 http://dx.doi.org/10.1007/s13205-018-1107-4 |
work_keys_str_mv | AT joannazeyland theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT magdalenahryhorowicz theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT agnieszkanowakterpiłowska theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT jacekjura theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT ryszardsłomski theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT zdzisławsmorag theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT barbaragajda theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT daniellipinski theproductionoful16bindingprotein1targetedpigsusingcrisprtechnology AT joannazeyland productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT magdalenahryhorowicz productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT agnieszkanowakterpiłowska productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT jacekjura productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT ryszardsłomski productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT zdzisławsmorag productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT barbaragajda productionoful16bindingprotein1targetedpigsusingcrisprtechnology AT daniellipinski productionoful16bindingprotein1targetedpigsusingcrisprtechnology |